2100 is the independent terminal for longevity medicine: what's actually available today, which clinics deliver it, what it costs, and how strong the evidence really is — from FDA-approved protocols to the reprogramming trials rewriting the field next. When you find something worth pursuing, we get you in the door.
Confidential concierge intake. A 2100 operator reviews your goals and routes you to the right clinic personally — usually within 48 hours. Free; the clinic compensates us only if you proceed, never you.
Aging-reversal medicine is scattered across private clinics, off-label scripts, and early trials with no public map. 2100 puts every credible option in one place — what it is, where to get it, what it costs, and an honest evidence rating, from large RCTs down to single-trial speculation.
You can afford the frontier. What you're missing is a clear map and a way in that isn't a cold email to a clinic that never replies. 2100 is the research desk and the introduction — built for serious buyers, not tire-kickers.
Named clinics. Where the protocols actually run. The further down the table, the further outside FDA jurisdiction — and the more recently the molecule reached the patient. Click any row for services, treatments offered, and pricing tiers.
| Clinic | Country | Tier |
|---|
Off-label prescriptions, OTC supplements, and procedures running today. Evidence ranges from large RCT (GLP-1) to single-trial speculation (HBOT, exosomes). Read the rating before reading the headline.
| Sym | Asset | Status | Evidence |
|---|
The frontier. Five categories, fourteen named programs, $3B+ in known capital. First human reprogramming results expected 2026-2027. Where today's "speculative" becomes tomorrow's standard of care.
| Sym | Program | Phase |
|---|
Measure first or you're flying blind. Epigenetic clocks compress 20-year mortality studies into a 6-month feedback loop — the most important development in this guide.
| Test | Best option | Cost |
|---|